highlights

AI in healthcare systems: realities, promises and contradictions of (still) imperfect adoption

The PHTI report analyzes the actual adoption of AI in U.S. healthcare systems: few tangible clinical benefits, limited transparency, and a high risk of bias. Italy can avoid the same mistakes by focusing on validation, interoperability, and industrial accountability.

The New World of Global Health

WHO relaunches global health with the 2025–2028 strategy, focusing on equity, resilience, and collaboration. Climate, access to medicines, innovation, and stronger health systems are at the heart of an agenda that also calls the pharmaceutical industry to action.

Business

CE marking for substance-based medical devices and drug-device combination products

BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices

Natural Raw Materials and Speciality Chemicals for the Italian Life Science Market

Deimos Group is a leading distributor of raw materials, ingredients and speciality chemicals for industries operating in Pharmaceutical, Pharma Intermediates, Nutraceutical, Food, Cosmetic, Animal Nutrition, Agricultural and Industrial sectors

MAGAZINE

MakingPharmaIndustry | The Magazine of the Pharma World | Issue 1_2025

This special issue explores the impact of automation and AI on pharmaceutical production—across GxP, sustainability, and digitalization.

MakingPharmaIndustry | March 2025 | Issue 1

In the March multimedia magazine, we explore the impact of artificial intelligence and cybersecurity regulations in the pharmaceutical industry. As artificial intelligence reshapes drug development,...
spot_img
spot_img
spot_img
spot_img